综合生物信息学分析和实验验证揭示了ALOX5AP与质瘤的预后和免疫微环境之间的关系

Ping Song1, Hui Deng1, Yushu Liu1

  • 1Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, 430030, P.R. China.

BMC medical genomics
|August 21, 2024
PubMed
概括

阿拉基酸5-氧激酶激活蛋白 (ALOX5AP) 在质瘤中高度表达,特别是在M2巨中. 升高的ALOX5AP表明预后较差,并预测质瘤患者对免疫治疗的反应降低.